State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics Chinese Academy of Sciences; Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012), Shanghai, 200050, P. R. China.
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
Adv Healthc Mater. 2022 Sep;11(17):e2200031. doi: 10.1002/adhm.202200031. Epub 2022 Jun 19.
Developing efficient and highly sensitive diagnostic techniques for early detections of pathogenic viruses such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is vitally important for preventing its widespread. However, the conventional polymerase chain reaction (PCR)-based detection features high complexity, excessive time-consumption, and labor-intensiveness, while viral protein-based detections suffer from moderate sensitivity and specificity. Here, a non-PCR but ultrasensitive viral RNA detection strategy is reported based on a facile nanoprobe-coupling strategy without enzymatic amplification, wherein PCR-induced bias and other shortcomings are successfully circumvented. This approach endows the viral RNA detection with ultra-low background to maximum signal ratio in the linear signal amplification by using Au nanoparticles as reporters. The present strategy exhibits 100% specificity toward SARS-CoV-2 N gene, and ultrasensitive detection of as low as 52 cp mL of SARS-CoV-2 N gene without pre-PCR amplification. This approach presents a novel ultrasensitive tool for viral RNA detections for fighting against COVID-19 and other types of pathogenic virus-caused diseases.
开发高效、高灵敏度的诊断技术,用于早期检测致病病毒,如严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2),对于防止其广泛传播至关重要。然而,传统的基于聚合酶链反应(PCR)的检测方法具有复杂性高、耗时耗力的特点,而基于病毒蛋白的检测方法则存在中等灵敏度和特异性的问题。在这里,我们报道了一种非 PCR 但超灵敏的病毒 RNA 检测策略,该策略基于一种简单的纳米探针偶联策略,无需酶扩增,从而成功避免了 PCR 诱导的偏差和其他缺点。该方法利用金纳米粒子作为报告分子,在线性信号放大过程中实现了超低背景至最大信号比的超灵敏病毒 RNA 检测。该策略对 SARS-CoV-2 N 基因具有 100%的特异性,并且无需预 PCR 扩增即可检测到低至 52 cp mL 的 SARS-CoV-2 N 基因。该方法为抗击 COVID-19 和其他类型的致病病毒引起的疾病提供了一种新的超灵敏病毒 RNA 检测工具。